Safflower yellow for acute ischemic stroke: A systematic review of randomized controlled trials

Complementary Therapies in Medicine

Volumn 22, Issue 2, 2014, Pages 354-361

  Fan, Siyuan ^a   Lin, Nan ^a   Shan, Guangliang ^b   Zuo, Pingping ^b   Cui, Liying ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

Acute ischemic stroke; Meta analysis; Safflower yellow; Systematic review

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; NEUROPROTECTIVE AGENT; NORPHENAZONE; PLANT EXTRACT; PLASMA SUBSTITUTE; SAFFLOWER YELLOW EXTRACT; UNCLASSIFIED DRUG; CHALCONE; SAFFLOWER YELLOW;

ACUTE DISEASE; ANTICOAGULATION; BRAIN INFARCTION; BRAIN ISCHEMIA; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; FOLLOW UP; HUMAN; MODIFIED EDINBURGH SCANDINAVIAN STROKE SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL (TOPIC); RASH; REVIEW; SAFFLOWER; SCORING SYSTEM; STATISTICAL BIAS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; ANALOGS AND DERIVATIVES; META ANALYSIS; STROKE;

CHALCONE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STROKE;

EID: 84898826815     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.01.001     Document Type: Review

References (74)

1. Murray C.J., Lopez A.D. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997, 349:1269-1276.
2. Lopez A.D., Mathers C.D., Ezzati M., et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 367:1747-1757.
3. He J., Gu D., Wu X., et al. Major causes of death among men and women in China. New Engl J Med 2005, 353:1124-1134.
4. Feigin L.V., Lawes M.C., Bennett A.D., et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2:43-53.
5. Hacke W., Kaste M., Bluhmki E., et al. Thrombolysis with alteplase 3 to 4.5h after acute ischemic stroke. New Engl J Med 2008, 359:1317-1329.
6. Guo M.L., Fu L.B., Zhang Z.Y., et al. Determination of safflower yellow, polysaccharide and adenosine in Carthamus tinctorius by UV and HPLC. Zhongguo Yao Xue Za Zhi 1999, 34:550-552.
7. Yang Z.F., Mei Q.B., Jiang Y.P. The effective components and pharmacological effects of safflower. Xi Bei Yao Xue Za Zhi 2001, 16:131-133.
8. Zang B.X., Jin M., Si N., et al. Antagonistic effect of hydroxysafflor yellow A on the platelet activating factor receptor. Yao Xue Xue Bao 2002, 37:696-699.
9. Zhu H., Wang Z., Ma C., et al. Neuroprotective effects of hydroxysafflor yellow A: in vivo and in vitro studies. Planta Medica 2003, 69:429-433.
10. Liang H., Fan J.Y., Li A.H., et al. The influence of hydrosafflow yellow A on the expression of NMDAR_1 in rat focal cerebral ischemia-reperfusion model. Zhonghua Lao Nian Xin Nao Xue Guan Bing Za Zhi 2004, 6:194-196.
11. Tian J.W., Fu F.H., Jiang W.L., et al. Protective effect of hydroxysafflor yellow A against rat cortex mitochondrial injuries induced by cerebral ischemia. Yao Xue Xue Bao 2004, 39:774-777.
12. Wei X., Liu H., Sun X., et al. Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action. Neurosci Lett 2005, 386:58-62.
13. Zhu H.B., Wang Z.H., Tian J.W., et al. Protective effect of hydroxysafflor yellow A on experimental cerebral ischemia in rats. Yao Xue Xue Bao 2005, 40:1144-1146.
14. Zhu H.B., Zhang L., Wang Z.H., et al. Therapeutic effects of hydroxysafflor yellow A on focal cerebral ischemic injury in rats and its primary mechanisms. J Asian Nat Prod Res 2005, 7:607-613.
15. Chen H.Y., Lin W.T. Observation on the effect of safflower yellow for ischemic stroke. Xian Dai Zhong Xi Yi Jie He Za Zhi 2008, 17:2166-2167.
16. Ji D.B., Zhu M.C., Zhu B., et al. Hydroxysafflor yellow A enhances survival of vascular endothelial cells under hypoxia via upregulation of the HIF-1 alpha-VEGF pathway and regulation of Bcl-2/Bax. J Cardiovasc Pharmacol 2008, 52:191-202.
17. Lian Z.Q., Zhao D.L., Zhu H.B. Hydroxysafflor yellow A up-regulates HIF-1alpha via inhibition of VHL and p53 in Eahy 926 cell line exposed to hypoxia. Yao Xue Xue Bao 2008, 43:484-489.
18. Tian J., Li G., Liu Z., et al. Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action. Pharmacology 2008, 82:121-126.
19. Ye S.Y., Gao W.Y. Hydroxysafflor yellow A protects neuron against hypoxia injury and suppresses inflammatory responses following focal ischemia reperfusion in rats. Arch Pharm Res 2008, 31:1010-1015.
20. Ji D.B., Zhang L.Y., Li C.L., et al. Effect of hydroxysafflor yellow A on human umbilical vein endothelial cells under hypoxia. Vasc Pharmacol 2009, 50:137-145.
21. Sun X., Wei X., Qu S., et al. Hydroxysafflor yellow A suppresses thrombin generation and inflammatory responses following focal cerebral ischemia-reperfusion in rats. Bioorg Med Chem Lett 2010, 20:4120-4124.
22. Yang Q., Yang Z.F., Liu S.B., et al. Neuroprotective effects of hydroxysafflor yellow A against excitotoxic neuronal death partially through down-regulation of NR2B-containing NMDA receptors. Neurochem Res 2010, 35:1353-1360.
23. Fan L., Dang X., Shi Z., et al. Hydroxysafflor yellow A protects PC12 cells against the apoptosis induced by oxygen and glucose deprivation. Cell Mol Neurobiol 2011, 31:1187-1194.
24. Wang X., Zang B., Wu W., et al. Protective effect of hydroxysafflor yellow A on endothelial cell injury induced by lipopolysaccharide. Zhongguo Zhong Yao Za Zhi 2011, 36:1650-1653.
25. Sun L., Yang L., Xu Y.W., et al. Neuroprotection of hydroxysafflor yellow A in the transient focal ischemia: inhibition of protein oxidation/nitration, 12/15-lipoxygenase and blood-brain barrier disruption. Brain Res 2012, 1473:227-235.
26. Li R., Guo M., Zhang G., et al. Neuroprotection of nicotiflorin in permanent focal cerebral ischemia and in neuronal cultures. Biol Pharm Bull 2006, 29:1868-1872.
27. Huang J.L., Fu S.T., Jiang Y.Y., et al. Protective effects of nicotiflorin on reducing memory dysfunction, energy metabolism failure and oxidative stress in multi-infarct dementia model rats. Pharmacol Biochem Behav 2007, 86:741-748.
28. Wang C., Zhang D., Li G., et al. Neuroprotective effects of safflower yellow B on brain ischemic injury. Exp Brain Res 2007, 177:533-539.
29. Thorvaldsen P., Asplund K., Kuulasmaa K., et al. Stroke incidence, case fatality, and mortality in the WHO MONICA project. World health organization monitoring trends and determinants in cardiovascular disease. Stroke 1995, 26:361-367.
30. Chinese Society of Neurology Diagnostic criteria and disability scale for cerebrovascular diseases. Zhonghua Shen Jing Ke Za Zhi 1996, 29:379-380.
31. Liu Y.L., Yang Y.P. Observation on the effect of letan injection for ischemic stroke. Zhongguo Shi Yong Shen Jing Ji Bing Za Zhi 2008, 11:68-69.
32. Chen L., Yun J.P. The observation on safflower yellow in treating acute cerebral infarction. Hai Xia Yi Xue 2009, 21:115-116.
33. Geng C., Zhao L.J., Shi C.Y. Effect of safflower yellow on serum ET-1 in patients with acute cerebral infarction. Zhongguo Zhong Yi Ji Zheng 2010, 19:1668-1669.
34. Huang X.Y. Clinical observation of safflower yellow plus edaravone injection for acute cerebral infarction: a report of 60 cases. Xian Dai Yi Yao Wei Sheng 2011, 27:3294-3295.
35. Ma Z.L., Wu B.X., Chen D.M., et al. Clinical observation on the effects of safflower yellow in treating acute cerebral infarction. Zhongguo Shi Yong Shen Jing Ji Bing Za Zhi 2011, 14:30-31.
36. Shi D.H., Zhang H.T., Zhao M.Y., et al. The clinical research of safflower yellow pigment on serum level of SOD MDA and CAT in acute cerebral infarction. Zhongguo Shi Yong Yi Kan 2011, 38:48-50.
37. Wang Z.Y. Effective observation on treating 50 cases of acute cerebral infarction with Honghua Huangse Su injection. Zhong Yi Lin Chuang Yan Jiu 2011, 3:23-24.
38. Lin C.S., Fang Y.S., Lin Y., et al. The safflower yellow pigment on the aggregation of blood coagulation in the cerebral infarction. Ji Ceng Yi Xue Lun Tan 2010, 14:502-503.
39. Ye B., Li W.J., Zheng L., et al. Effect of safflower yellow pigment on blood rheology and cerebral hemodynamics in patients with acute cerebral infarction. Zhonghua Quan Ke Yi Xue 2012, 10:219-221.
40. Du Y.H.Y Clinical research of safflower yellow injection for acute cerebral infarction: a clinical study of 60 cases. Hebei: Hebei Da Xue Zhong Yi Xue Yuan 2006.
41. Pan S.B. Safflor yellow injection for acute cerebral infarction consistent with syndrome of static blood blocking collaterals: a clinical study of 70 cases. Hebei: Hebei Da Xue Zhong Yi Xue Yuan 2006.
42. Shi W.J., Zhao L.Y. Observation on the effect of safflower yellow for transient ischemic attack. Xian Dai Zhong Xi Yi Jie He Za Zhi 2008, 17:5005-5006.
43. Ma J.F., Chen K.Y. The clinical effects of safflow yellow with weinaolutong in treating acute cerebral infarction. Ya Tai Chuan Tong Yi Yao 2011, 7:73-74.
44. Li L.J., Shang D.S., Du H.M., et al. Treatment of cerebral infarction in acute stage with safflower yellow for injection. Ya Tai Chuan Tong Yi Yao (Zhong Yi Lin Chuang) 2008, 15:1-4.
45. Jiang H. Pharmacological effect and clinical observation of safflower yellow. Zhongguo Zhong Yi Yao Zi Xun 2011, 20:205.
46. Chen J.P. Effects of henghuahuangsesu injection on cerebral infarction: a report of 60 cases. Yi Xue Xin Xi 2009, 1:122.
47. Cu Z.X. Clinical observation of injection safflower yellow pigment on treating stroke blood stasis syndrome (cerebral infarction). Hubei: Hubei Zhong Yi Yao Da Xue 2012.
48. Dai F.S., Liu Z.K. Clinical observation on danhong injection for acute cerebral infarction. Qingdao Yi Yao Wei Sheng 2009, 41:208-210.
49. Dong Q.J. Analysis of the effect of safflower yellow injection with cerebroprotein hydrolysate for acute cerebral infarction. Shi Yong Xin Nao Fei Xue Guan Za Zhi 2012, 20:1928-1929.
50. Duan S.J., Ren X., Ju X.H., et al. Clinical observation of edaravone injection with safflower yellow for acute cerebral infarction: a report of 60 cases. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2011, 9:498-499.
51. Jin H.Y. Observation on the effect of safflower yellow injection for acute cerebral infarction. Yi Yao Qian Yan 2012, 2:116-117.
52. Jin Y., He H.L., Wang H.Y. Safflower yellow injection for acute cerebral infarction: a report of 46 cases. Yi Yao Dao Bao 2010, 29:177-179.
53. Le S., Liu Z.H. The clinical study on safflower yellow injection combined with low molecular heparin in treating acute cerebral infarction. Zhongguo Shi Yong Lin Chuang Yi Xue 2009, 3:36-37.
54. Liang Q.W. Study on clinical effects and functional mechanism on brain ischemic injury by honghuahuang se su capsule. Hunan: Hunan Zhong Yi Yao Da Xue 2007.
55. Liu H.Z. Clinical analysis of safflower yellow for acute multiple cerebral lacunar infarction: a report of 62 cases. Jilin Yi Xue 2012, 33:3454-3455.
56. Liu X.Y., Zheng J.Y. Observation on the effect of safflower yellow for ischemic stroke. Nao Yu Shen Jing Ji Bing Za Zhi 2008, 16:132-133.
57. Qiu M., He S.D., Wang F. Observation on the effect of edaravone injection with safflower yellow for acute cerebral infarction: a report of 40 cases. Hainan Yi Xue 2011, 22:65-66.
58. Song F.Y., Chen C.L., Wang C.L. The influence of safflower yellow with shuxuetong on the hemorheology of patients with acute cerebral infarction. Zhongguo Shi Yong Shen Jing Ji Bing Za Zhi 2011, 14:49-51.
59. Wang L.Q., Li L.L. Observation on the effect of safflower yellow injection for ischemic stroke. Zhong Xi Yi Jie He Xin Nao Xue Guan Bing Za Zhi 2012, 10:761-762.
60. Xing Y.L., Tu Q., Xiao Q.F., et al. Clinical effect of honghuahuangsesu injection on ischemic apoplexy. Zhongguo Yi Yuan Yao Xue Za Zhi 2008, 28:1493-1495.
61. Yu J.X. Study of lumbrukinase with safflower yellow for acute cerebral infarction: a report of 50 cases. Jiangxi Zhong Yi Yao 2010, 41:39-40.
62. Zhang L.P., Pei L.X., Ye W., et al. Clinical efficacy of cinepazide maleate combined with carthamus yellow in treatment of acute cerebrai infarction. Zhongguo Yao Shi 2009, 12:1793-1794.
63. Zhang X., Fang L., Niu X.L., et al. Effects of safflower yellow injection on nervous function of acute cerebral infarction. Beihua Da Xue Xue Bao (Zi Ran Ke Xue Ban) 2009, 10:518-520.
64. Zhang Y., Hu Y., Mu Z.B., et al. Clinical study of safflower yellow combined with edaravone as treatment of acute cerebral infarction. Yi Xue Zong Shu 2012, 18:2514-2515.
65. Zhang Y.P. Observation on the effect of safflower yellow combined with edaravone as treatment of acute cerebral infarction. Zhongguo Shi Yong Yi Yao 2012, 7:131-132.
66. Zhao Y. Clinical study of safflower yellow combined with edaravone as treatment of acute cerebral infarction. An Mo Yu Kang Fu Yi Xue 2012, 3:15.
67. Brott T., Adams H.J., Olinger C., et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989, 20:864-870.
68. Dong Q., Wu D.C. Comparisons of different neurological deficit scoring: an analysis of 193 cases. Zhongguo Lin Chuang Shen Jing Ke Xue 2000, 8:189-191.
69. Hu F.M., Huang Z.X. Literature review of safflower yellow for acute cerebral infarction. Chang Jiang Da Xue Xue Bao (Zi Ran Ke Xue) 2012, 9:59-61.
70. Zhu D.S., Wang L.M., Fu X.J. Meta-analysis of safflower yellow injection for acute cerebral infarction. Zhongguo Yao Wu Yu Lin Chuang 2011, 11:1026-1029.
71. Cui H.J., He H.Y., Xing Z.H. Meta-analysis of safflower yellow injection for the treatment of the overall effectiveness power and safety of acute cerebral infarction. Zhong Cheng Yao 2011, 33:1299-1302.
72. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke. New Engl J Med 1995, 333:1581-1587.
73. Tu Y. The discovery of artemisinin (qinghaosu) and gifts from Chinese medicine. Nat Med 2011, 17:1217-1220.
74. Wang Z.Y., Chen Z. Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 2008, 111:2505-2515.